Roivant Sciences Ltd banner

Roivant Sciences Ltd
F:87S

Watchlist Manager
Roivant Sciences Ltd Logo
Roivant Sciences Ltd
F:87S
Watchlist
Price: 24.04 EUR 1.31%
Market Cap: €17.8B

Profitability Summary

Roivant Sciences Ltd's profitability score is 35/100. We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

35/100
Profitability
Score

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

35/100
Profitability
Score
35/100
Profitability
Score

Margins

Earnings Waterfall
Roivant Sciences Ltd

Margins Comparison
Roivant Sciences Ltd Competitors

Country Company Market Cap Gross
Margin
Operating
Margin
Net
Margin
UK
Roivant Sciences Ltd
F:87S
17.1B EUR
Loading...
Loading...
Loading...
FR
Pharnext SCA
OTC:PNEXF
6T USD
Loading...
Loading...
Loading...
US
Abbvie Inc
NYSE:ABBV
412.7B USD
Loading...
Loading...
Loading...
US
Amgen Inc
NASDAQ:AMGN
206.6B USD
Loading...
Loading...
Loading...
US
Gilead Sciences Inc
NASDAQ:GILD
186.2B USD
Loading...
Loading...
Loading...
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
123.6B USD
Loading...
Loading...
Loading...
US
Epizyme Inc
F:EPE
94.1B EUR
Loading...
Loading...
Loading...
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
83.1B USD
Loading...
Loading...
Loading...
AU
CSL Ltd
ASX:CSL
70B AUD
Loading...
Loading...
Loading...
NL
argenx SE
XBRU:ARGX
39.4B EUR
Loading...
Loading...
Loading...
US
Seagen Inc
F:SGT
39.3B EUR
Loading...
Loading...
Loading...

Return on Capital

Return on Capital Comparison
Roivant Sciences Ltd Competitors

Country Company Market Cap ROE ROA ROCE ROIC
UK
Roivant Sciences Ltd
F:87S
17.1B EUR
Loading...
Loading...
Loading...
Loading...
FR
Pharnext SCA
OTC:PNEXF
6T USD
Loading...
Loading...
Loading...
Loading...
US
Abbvie Inc
NYSE:ABBV
412.7B USD
Loading...
Loading...
Loading...
Loading...
US
Amgen Inc
NASDAQ:AMGN
206.6B USD
Loading...
Loading...
Loading...
Loading...
US
Gilead Sciences Inc
NASDAQ:GILD
186.2B USD
Loading...
Loading...
Loading...
Loading...
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
123.6B USD
Loading...
Loading...
Loading...
Loading...
US
Epizyme Inc
F:EPE
94.1B EUR
Loading...
Loading...
Loading...
Loading...
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
83.1B USD
Loading...
Loading...
Loading...
Loading...
AU
CSL Ltd
ASX:CSL
70B AUD
Loading...
Loading...
Loading...
Loading...
NL
argenx SE
XBRU:ARGX
39.4B EUR
Loading...
Loading...
Loading...
Loading...
US
Seagen Inc
F:SGT
39.3B EUR
Loading...
Loading...
Loading...
Loading...

Free Cash Flow

Free Cash Flow Analysis
Roivant Sciences Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett